Literature DB >> 9973279

High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands.

P Rizzu1, J C Van Swieten, M Joosse, M Hasegawa, M Stevens, A Tibben, M F Niermeijer, M Hillebrand, R Ravid, B A Oostra, M Goedert, C M van Duijn, P Heutink.   

Abstract

Mutations in microtubule-associated protein tau recently have been identified in familial cases of frontotemporal dementia (FTD). We report the frequency of tau mutations in a large population-based study of FTD carried out in the Netherlands from January 1994 to June 1998. Thirty-seven patients had >/=1 first-degree relative with dementia. A mutation in the tau gene was found in 17.8% of the group of patients with FTD and in 43% of patients with FTD who also had a positive family history of FTD. Three distinct missense mutations (G272V, P301L, R406W) accounted for 15.6% of the mutations. These three missense mutations, and a single amino acid deletion (DeltaK280) that was detected in one patient, strongly reduce the ability of tau to promote microtubule assembly. We also found an intronic mutation at position +33 after exon 9, which is likely to affect the alternative splicing of tau. Tau mutations are responsible for a large proportion of familial FTD cases; however, there are also families with FTD in which no mutations in tau have been found, which indicates locus and/or allelic heterogeneity. The different tau mutations may result in disturbances in the interactions of the protein tau with microtubules, resulting in hyperphosphorylation of tau protein, assembly into filaments, and subsequent cell death.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9973279      PMCID: PMC1377751          DOI: 10.1086/302256

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  40 in total

1.  Structure and novel exons of the human tau gene.

Authors:  A Andreadis; W M Brown; K S Kosik
Journal:  Biochemistry       Date:  1992-11-03       Impact factor: 3.162

2.  Effects of brain microtubule-associated proteins on microtubule dynamics and the nucleating activity of centrosomes.

Authors:  M H Bré; E Karsenti
Journal:  Cell Motil Cytoskeleton       Date:  1990

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis.

Authors:  L Gustafson
Journal:  Arch Gerontol Geriatr       Date:  1987-09       Impact factor: 3.250

5.  Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology.

Authors:  A Brun
Journal:  Arch Gerontol Geriatr       Date:  1987-09       Impact factor: 3.250

6.  Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia.

Authors:  D S Knopman; A R Mastri; W H Frey; J H Sung; T Rustan
Journal:  Neurology       Date:  1990-02       Impact factor: 9.910

7.  Dementia of frontal lobe type.

Authors:  D Neary; J S Snowden; B Northen; P Goulding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-03       Impact factor: 10.154

8.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

9.  Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization.

Authors:  M Goedert; R Jakes
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

10.  Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain.

Authors:  M Goedert; M G Spillantini; M C Potier; J Ulrich; R A Crowther
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

View more
  99 in total

1.  Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17.

Authors:  L Varani; M Hasegawa; M G Spillantini; M J Smith; J R Murrell; B Ghetti; A Klug; M Goedert; G Varani
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

Review 2.  Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

Authors:  M Goedert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

Review 3.  Frontotemporal dementia and tauopathy.

Authors:  Y Yoshiyama; V M Lee; J Q Trojanowski
Journal:  Curr Neurol Neurosci Rep       Date:  2001-09       Impact factor: 5.081

4.  Two families with familial amyotrophic lateral sclerosis are linked to a novel locus on chromosome 16q.

Authors:  Deborah M Ruddy; Matthew J Parton; Ammar Al-Chalabi; Cathryn M Lewis; Caroline Vance; Bradley N Smith; P Nigel Leigh; John F Powell; Teepu Siddique; Eelco Postumus Meyjes; Frank Baas; Vianney de Jong; Christopher E Shaw
Journal:  Am J Hum Genet       Date:  2003-07-01       Impact factor: 11.025

5.  Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta.

Authors:  Zhihong Jiang; Hao Tang; Necat Havlioglu; Xiaochun Zhang; Stefan Stamm; Riqiang Yan; Jane Y Wu
Journal:  J Biol Chem       Date:  2003-03-20       Impact factor: 5.157

6.  Competition for microtubule-binding with dual expression of tau missense and splice isoforms.

Authors:  M Lu; K S Kosik
Journal:  Mol Biol Cell       Date:  2001-01       Impact factor: 4.138

7.  Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein.

Authors:  K Spittaels; C Van den Haute; J Van Dorpe; K Bruynseels; K Vandezande; I Laenen; H Geerts; M Mercken; R Sciot; A Van Lommel; R Loos; F Van Leuven
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

8.  The acetylation of tau inhibits its function and promotes pathological tau aggregation.

Authors:  Todd J Cohen; Jing L Guo; David E Hurtado; Linda K Kwong; Ian P Mills; John Q Trojanowski; Virginia M Y Lee
Journal:  Nat Commun       Date:  2011       Impact factor: 14.919

Review 9.  Cellular factors modulating the mechanism of tau protein aggregation.

Authors:  Sarah N Fontaine; Jonathan J Sabbagh; Jeremy Baker; Carlos R Martinez-Licha; April Darling; Chad A Dickey
Journal:  Cell Mol Life Sci       Date:  2015-02-11       Impact factor: 9.261

Review 10.  Alternative splicing and disease.

Authors:  Jamal Tazi; Nadia Bakkour; Stefan Stamm
Journal:  Biochim Biophys Acta       Date:  2008-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.